{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T23:13:13Z","timestamp":1775603593472,"version":"3.50.1"},"reference-count":29,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,5,20]],"date-time":"2022-05-20T00:00:00Z","timestamp":1653004800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["EXPL\/BBB-BIO\/1541\/2013 IF\/01704\/2014\/CP1229\/CT0001 SFRH\/BD\/138937\/2018"],"award-info":[{"award-number":["EXPL\/BBB-BIO\/1541\/2013 IF\/01704\/2014\/CP1229\/CT0001 SFRH\/BD\/138937\/2018"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004712","name":"Interface","doi-asserted-by":"publisher","award":["UIDB\/04462\/2020 UIDP\/04462\/2020"],"award-info":[{"award-number":["UIDB\/04462\/2020 UIDP\/04462\/2020"]}],"id":[{"id":"10.13039\/100004712","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["730964 951668"],"award-info":[{"award-number":["730964 951668"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Bioeng. Biotechnol."],"abstract":"<jats:p><jats:italic>Plasmodium falciparum<\/jats:italic> cysteine-rich protective antigen (<jats:italic>Pf<\/jats:italic>CyRPA) has been identified as a promising blood-stage candidate antigen to include in a broadly cross-reactive malaria vaccine. In the last couple of decades, substantial effort has been committed to the development of scalable cost-effective, robust, and high-yield <jats:italic>Pf<\/jats:italic>CyRPA production processes. Despite insect cells being a suitable expression system due to their track record for protein production (including vaccine antigens), these are yet to be explored to produce this antigen. In this study, different insect cell lines, culture conditions (baculovirus infection strategy, supplementation schemes, culture temperature modulation), and purification strategies (affinity tags) were explored aiming to develop a scalable, high-yield, and high-quality <jats:italic>Pf<\/jats:italic>CyRPA for inclusion in a virosome-based malaria vaccine candidate. Supplements with antioxidants improved <jats:italic>Pf<\/jats:italic>CyRPA volumetric titers by 50% when added at the time of infection. In addition, from three different affinity tags (6x-His, 4x-His, and C-tag) evaluated, the 4x-His affinity tag was the one leading to the highest <jats:italic>Pf<\/jats:italic>CyRPA purification recovery yields (61%) and production yield (26\u00a0mg\/L vs. 21\u00a0mg\/L and 13\u00a0mg\/L for 6x-His and C-tag, respectively). Noteworthy, <jats:italic>Pf<\/jats:italic>CyRPA expressed using High Five cells did not show differences in protein quality or stability when compared to its human HEK293 cell counterpart. When formulated in a lipid-based virosome nanoparticle, immunized rabbits developed functional anti-<jats:italic>Pf<\/jats:italic>CyRPA antibodies that impeded the multiplication of <jats:italic>P. falciparum in vitro<\/jats:italic>. This work demonstrates the potential of using IC-BEVS as a qualified platform to produce functional recombinant <jats:italic>Pf<\/jats:italic>CyRPA protein with the added benefit of being a non-human expression system with short bioprocessing times and high expression levels.<\/jats:p>","DOI":"10.3389\/fbioe.2022.879078","type":"journal-article","created":{"date-parts":[[2022,5,20]],"date-time":"2022-05-20T07:55:40Z","timestamp":1653033340000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":10,"title":["Scalable Process for High-Yield Production of PfCyRPA Using Insect Cells for Inclusion in a Malaria Virosome-Based Vaccine Candidate"],"prefix":"10.3389","volume":"10","author":[{"given":"B\u00e1rbara","family":"Fernandes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcos","family":"Sousa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rute","family":"Castro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anja","family":"Sch\u00e4fer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia","family":"Hauser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kai","family":"Schulze","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario","family":"Amacker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Tamborrini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerd","family":"Pluschke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paula M","family":"Alves","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sylvain","family":"Fleury","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ant\u00f3nio","family":"Rold\u00e3o","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,5,20]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"S71","DOI":"10.1111\/j.1748-5967.2008.00177.x","article-title":"Production of Therapeutic Proteins with Baculovirus Expression System in Insect Cell","volume":"38","author":"Ahn","year":"2008","journal-title":"Entomol. Res."},{"key":"B2","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/s41541-020-0190-9","article-title":"New GMP Manufacturing Processes to Obtain Thermostable HIV-1 Gp41 Virosomes under Solid Forms for Various Mucosal Vaccination Routes","volume":"5","author":"Amacker","year":"2020","journal-title":"Npj Vaccin."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pep.2005.12.002","article-title":"Current Strategies for the Use of Affinity Tags and Tag Removal for the Purification of Recombinant Proteins","volume":"48","author":"Arnau","year":"2006","journal-title":"Protein Expr. Purif."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.2147\/RMHP.S219294","article-title":"Towards Eradication of Malaria: Is the WHO's RTS,S\/AS01 Vaccination Effective Enough?","author":"Arora","year":"2021","journal-title":"Rmhp"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1002\/bit.21364","article-title":"Improving AAV Vector Yield in Insect Cells by Modulating the Temperature after Infection","volume":"97","author":"Aucoin","year":"2007","journal-title":"Biotechnol. Bioeng."},{"key":"B6","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/s0076-6879(00)26058-8","article-title":"[16] Purification of Proteins Using Polyhistidine Affinity Tags","volume":"326","author":"Bornhorst","year":"2000","journal-title":"Methods Enzymol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.vaccine.2012.10.106","article-title":"A Full-Length Recombinant Plasmodium Falciparum PfRH5 Protein Induces Inhibitory Antibodies that Are Effective across Common PfRH5 Genetic Variants","volume":"31","author":"Bustamante","year":"2013","journal-title":"Vaccine"},{"key":"B8","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.ymben.2009.08.008","article-title":"Improving Baculovirus Production at High Cell Density through Manipulation of Energy Metabolism","volume":"12","author":"Carinhas","year":"2010","journal-title":"Metab. Eng."},{"key":"B9","doi-asserted-by":"publisher","first-page":"589","DOI":"10.3390\/vaccines8040589","article-title":"Improving Influenza HA-Vlps Production in Insect High Five Cells via Adaptive Laboratory Evolution","volume":"8","author":"Correia","year":"2020","journal-title":"Vaccines"},{"key":"B10","doi-asserted-by":"publisher","first-page":"6225","DOI":"10.4049\/jimmunol.1103177","article-title":"Passive Immunoprotection ofPlasmodium Falciparum-Infected Mice Designates the CyRPA as Candidate Malaria Vaccine Antigen","volume":"188","author":"Dreyer","year":"2012","journal-title":"J.I."},{"key":"B11","doi-asserted-by":"publisher","first-page":"9e","DOI":"10.1093\/nar\/30.2.e9","article-title":"High-level and High-Throughput Recombinant Protein Production by Transient Transfection of Suspension-Growing Human 293-EBNA1 Cells","volume":"30","author":"Durocher","year":"2002","journal-title":"Nucleic Acids Res."},{"key":"B12","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1186\/s12936-016-1213-x","article-title":"Generation of Plasmodium Falciparum Parasite-Inhibitory Antibodies by Immunization with Recombinantly-Expressed CyRPA","volume":"15","author":"Favuzza","year":"2016","journal-title":"Malar. J."},{"key":"B13","doi-asserted-by":"publisher","first-page":"e20383","DOI":"10.7554\/eLife.20383","article-title":"Structure of the Malaria Vaccine Candidate Antigen CyRPA and its Complex with a Parasite Invasion Inhibitory Antibody","volume":"6","author":"Favuzza","year":"2017","journal-title":"ELife"},{"key":"B14","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.jbiotec.2019.10.004","article-title":"Adaptive Laboratory Evolution of Stable Insect Cell Lines for Improved HIV-Gag VLPs Production","volume":"307","author":"Fernandes","year":"2020","journal-title":"J. Biotechnol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"30357","DOI":"10.1038\/srep30357","article-title":"Production of Full-Length Soluble Plasmodium Falciparum RH5 Protein Vaccine Using a Drosophila melanogaster Schneider 2 Stable Cell Line System","volume":"6","author":"Hjerrild","year":"2016","journal-title":"Sci. Rep."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0042-6822(03)00120-X","article-title":"Developing Baculovirus-Insect Cell Expression Systems for Humanized Recombinant Glycoprotein Production","volume":"310","author":"Jarvis","year":"2003","journal-title":"Virology"},{"key":"B17","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/j.ijpara.2016.12.001","article-title":"Accelerating the Clinical Development of Protein-Based Vaccines for Malaria by Efficient Purification Using a Four Amino Acid C-Terminal 'C-Tag'","volume":"47","author":"Jin","year":"2017","journal-title":"Int. J. Parasitol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1038\/nbt1095","article-title":"Baculovirus as Versatile Vectors for Protein Expression in Insect and Mammalian Cells","volume":"23","author":"Kost","year":"2005","journal-title":"Nat. Biotechnol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"260","DOI":"10.2144\/03342bm05","article-title":"Titration of Non-occluded Baculovirus Using a Cell Viability Assay","volume":"34","author":"Mena","year":"2003","journal-title":"BioTechniques"},{"key":"B20","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.jbiotec.2016.06.029","article-title":"Targeted Supplementation Design for Improved Production and Quality of Enveloped Viral Particles in Insect Cell-Baculovirus Expression System","volume":"233","author":"Monteiro","year":"2016","journal-title":"J. Biotechnol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.1093\/infdis\/jit385","article-title":"Plasmodium Falciparum Merozoite Surface Antigen, PfRH5, Elicits Detectable Levels of Invasion-Inhibiting Antibodies in Humans","volume":"208","author":"Patel","year":"2013","journal-title":"J. Infect. Dis."},{"key":"B22","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1007\/BF00350408","article-title":"Economics of Baculovirus?insect Cell Production Systems","volume":"20","author":"Rhodes","year":"1996","journal-title":"Cytotechnology"},{"key":"B23","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.jviromet.2009.03.007","article-title":"Error Assessment in Recombinant Baculovirus Titration: Evaluation of Different Methods","volume":"159","author":"Rold\u00e3o","year":"2009","journal-title":"J. Virol. Methods"},{"key":"B24","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/nmeth.2019","article-title":"Fiji: An Open-Source Platform for Biological-Image Analysis","volume":"9","author":"Schindelin","year":"2012","journal-title":"Nat. Methods"},{"key":"B25","doi-asserted-by":"publisher","first-page":"3112","DOI":"10.1016\/j.vaccine.2017.02.043","article-title":"Combining Stable Insect Cell Lines with Baculovirus-Mediated Expression for Multi-HA Influenza VLP Production","volume":"36","author":"Sequeira","year":"2018","journal-title":"Vaccine"},{"key":"B26","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.ymeth.2015.09.023","article-title":"Characterizing Enterovirus 71 and Coxsackievirus A16 Virus-like Particles Production in Insect Cells","volume":"95","author":"Somasundaram","year":"2016","journal-title":"Methods"},{"key":"B27","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.jbiotec.2005.03.026","article-title":"Triple Layered Rotavirus VLP Production: Kinetics of Vector Replication, mRNA Stability and Recombinant Protein Production","volume":"120","author":"Vieira","year":"2005","journal-title":"J. Biotechnol."},{"key":"B28","volume-title":"World Malaria Report 2021","year":"2021"},{"key":"B29","doi-asserted-by":"publisher","first-page":"10061","DOI":"10.1021\/acs.iecr.8b00985","article-title":"The Coming Age of Insect Cells for Manufacturing and Development of Protein Therapeutics","volume":"57","author":"Yee","year":"2018","journal-title":"Ind. Eng. Chem. Res."}],"container-title":["Frontiers in Bioengineering and Biotechnology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fbioe.2022.879078\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,20]],"date-time":"2022-05-20T07:55:45Z","timestamp":1653033345000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fbioe.2022.879078\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,20]]},"references-count":29,"alternative-id":["10.3389\/fbioe.2022.879078"],"URL":"https:\/\/doi.org\/10.3389\/fbioe.2022.879078","relation":{},"ISSN":["2296-4185"],"issn-type":[{"value":"2296-4185","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,20]]},"article-number":"879078"}}